Danone says 2025 outperformance and cost cuts set stage for confident 2026 outlook
Danone reported 2025 results that surpassed analyst expectations on sales and free cash flow, while cost reductions lifted its recurring operating margin. Strong demand for medical nutrition and baby food in China helped offset softness in U.S. coffee creamers. The company said the financial impact of infant formula recalls related to a cereulide c…